Your browser doesn't support javascript.
loading
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.
Hoang, Joseph K; Yang, Hwai-I; Le, An; Nguyen, Nghia H; Lin, Derek; Vu, Vinh D; Chaung, Kevin; Nguyen, Vincent; Trinh, Huy N; Li, Jiayi; Zhang, Jian Q; Chen, Chien-Jen; Nguyen, Mindie H.
Afiliação
  • Hoang JK; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA Genomics Research Center, Academia Sinica Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan Stanford Cancer Institute, Stanford Medicine, Stanford Department of Internal Medicine, University of California, San Diego Department of Medicine, Stanford University Medical Center, Stanford San Jose Gastroenterology, San Jose Gastroenterology, Palo Alto Medical Foundati
Medicine (Baltimore) ; 95(31): e4433, 2016 Aug.
Article em En | MEDLINE | ID: mdl-27495067

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite B Crônica / Transaminases / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite B Crônica / Transaminases / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article